A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Clinical trial NCT01895309 · COMPLETED
Trial details
- NCT number
- NCT01895309
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 596
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.